Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
iX Biopharma Ltd. ( (SG:42C) ) has shared an update.
iX Biopharma Ltd. held its Annual General Meeting (AGM) on October 24, 2025, chaired by Mr. Eddy Lee Yip Hang. The meeting was attended by the Board of Directors, shareholders, management, and other professionals. Voting was conducted by poll, with Tricor Barbinder Share Registration Services and CitadelCorp Pte. Ltd. appointed as polling agent and independent scrutineer, respectively. No questions were received in advance from shareholders, but attendees were given the opportunity to ask questions after each motion was proposed. The AGM proceeded with the Chairman proposing all resolutions.
More about iX Biopharma Ltd.
iX Biopharma Ltd. is a company incorporated in Singapore, operating in the biopharmaceutical industry. It focuses on the development and commercialization of innovative therapies, primarily targeting unmet medical needs in the pharmaceutical market.
Average Trading Volume: 14,397,260
Technical Sentiment Signal: Buy
Current Market Cap: S$121.4M
For detailed information about 42C stock, go to TipRanks’ Stock Analysis page.